Abstract
This report details the worldwide incidence and prevalence by country/region
of Type 1 and Type 2 diabetes and details the current and projected market for
diagnostic and therapeutic products in the management of diabetes, including
anti-diabetic drugs, alternative insulin types, blood glucose monitoring
(including continuous monitoring devices), insulin pumps, and other
established and emerging products in diabetes management. The report provides
an emphasis of detail on the status of development of novel products including
noninvasive monitoring, oral/inhaled/other insulin delivery. The report
details the clinical and technology developments underlying this huge and
evolving worldwide market, with data on products in development and on the
market; market size and forecast; competitor market shares; competitor
profiles; and market opportunity. Separate size, growth and competitor share
data are presented for the U.S., individual western European countries
(Belgium, Denmark, France, Germany, Italy, Netherlands, Norway, Spain, Sweden,
United Kingdom), and Japan. The report profiles active companies including
detailed profile information on major competitors, brief profiles of companies
with less sizeable current or potential positions in the market, and
appropriate additional profiles of companies with novel or advanced research
activities in the market.
The report establishes the current worldwide market size for major technology
segments as a baseline for and projecting growth in the market over a ten-year
forecast. The report also assesses and projects the composition of the market
as technologies gain or lose relative market performance over this period.
| 
View Cart
